228 related articles for article (PubMed ID: 21068389)
1. Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance.
Stark M; Bram EE; Akerman M; Mandel-Gutfreund Y; Assaraf YG
J Biol Chem; 2011 Feb; 286(5):3741-54. PubMed ID: 21068389
[TBL] [Abstract][Full Text] [Related]
2. Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation.
Blanquicett C; Gillespie GY; Nabors LB; Miller CR; Bharara S; Buchsbaum DJ; Diasio RB; Johnson MR
Mol Cancer Ther; 2002 Oct; 1(12):1139-45. PubMed ID: 12481438
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine.
Ko JC; Tsai MS; Kuo YH; Chiu YF; Weng SH; Su YC; Lin YW
Biochem Pharmacol; 2011 Mar; 81(5):680-90. PubMed ID: 21168393
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA.
Morita T; Matsuzaki A; Tokue A
Int J Cancer; 2001 May; 92(3):451-6. PubMed ID: 11291085
[TBL] [Abstract][Full Text] [Related]
5. Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer.
Andreetta C; Puppin C; Minisini A; Valent F; Pegolo E; Damante G; Di Loreto C; Pizzolitto S; Pandolfi M; Fasola G; Piga A; Puglisi F
Ann Oncol; 2009 Feb; 20(2):265-71. PubMed ID: 18765464
[TBL] [Abstract][Full Text] [Related]
6. [Improved sensitivity of gastric carcinoma cells to fluorouracil-related drugs by transfection of thymidine phosphorylase gene].
Zhuo LJ; Gao MQ; Huang AM
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):330-3. PubMed ID: 21756828
[TBL] [Abstract][Full Text] [Related]
7. Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.
Di Gennaro E; Piro G; Chianese MI; Franco R; Di Cintio A; Moccia T; Luciano A; de Ruggiero I; Bruzzese F; Avallone A; Arra C; Budillon A
Br J Cancer; 2010 Nov; 103(11):1680-91. PubMed ID: 21045833
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda.
Ait-Tihyaty M; Rachid Z; Mihalcioiu C; Jean-Claude BJ
Breast Cancer Res Treat; 2012 May; 133(1):217-26. PubMed ID: 21915635
[TBL] [Abstract][Full Text] [Related]
9. The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for head and neck cancer.
Saito K; Khan K; Yu SZ; Ronson S; Rhee J; Li G; Van Echo D; Suntharalingam M; O'Malley BW; Li D
Laryngoscope; 2009 Jan; 119(1):82-8. PubMed ID: 19117293
[TBL] [Abstract][Full Text] [Related]
10. Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells.
Chen LC; Liu HP; Li HP; Hsueh C; Yu JS; Liang CL; Chang YS
Oncogene; 2009 Apr; 28(17):1904-15. PubMed ID: 19330019
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression.
Terranova-Barberio M; Roca MS; Zotti AI; Leone A; Bruzzese F; Vitagliano C; Scogliamiglio G; Russo D; D'Angelo G; Franco R; Budillon A; Di Gennaro E
Oncotarget; 2016 Feb; 7(7):7715-31. PubMed ID: 26735339
[TBL] [Abstract][Full Text] [Related]
12. Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase?
Bonotto M; Bozza C; Di Loreto C; Osa EO; Poletto E; Puglisi F
Clin Breast Cancer; 2013 Jun; 13(3):167-72. PubMed ID: 23218471
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
Saif MW; Black G; Roy S; Bell D; Russo S; Eloubeidi MA; Steg A; Johnson MR; Zelterman D; Diasio RB
Cancer J; 2007; 13(4):247-56. PubMed ID: 17762760
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional role of thymidine phosphorylase in cancer.
Warfield BM; Reigan P
Trends Cancer; 2022 Jun; 8(6):482-493. PubMed ID: 35193822
[TBL] [Abstract][Full Text] [Related]
15. An epigenetic mechanism for capecitabine resistance in mesothelioma.
Kosuri KV; Wu X; Wang L; Villalona-Calero MA; Otterson GA
Biochem Biophys Res Commun; 2010 Jan; 391(3):1465-70. PubMed ID: 20035722
[TBL] [Abstract][Full Text] [Related]
16. Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer.
Puglisi F; Cardellino GG; Crivellari D; Di Loreto C; Magri MD; Minisini AM; Mansutti M; Andreetta C; Russo S; Lombardi D; Perin T; Damante G; Veronesi A
Ann Oncol; 2008 Sep; 19(9):1541-6. PubMed ID: 18441329
[TBL] [Abstract][Full Text] [Related]
17. Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma.
Kocakova I; Svoboda M; Kubosova K; Chrenko V; Roubalova E; Krejci E; Sefr R; Slampa P; Frgala T; Zaloudik J
Neoplasma; 2007; 54(5):447-53. PubMed ID: 17688376
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopy.
Chung YL; Troy H; Judson IR; Leek R; Leach MO; Stubbs M; Harris AL; Griffiths JR
Clin Cancer Res; 2004 Jun; 10(11):3863-70. PubMed ID: 15173095
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines.
Puppin C; Puglisi F; Pandolfi M; Di Loreto C; Damante G
Oncol Rep; 2011 Aug; 26(2):309-14. PubMed ID: 21617864
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma.
Chen LC; Hsueh C; Tsang NM; Liang Y; Chang KP; Hao SP; Yu JS; Chang YS
Clin Cancer Res; 2008 Jun; 14(12):3807-13. PubMed ID: 18559600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]